Financials

News Discussions Technicals Seasonals

4883 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Modalis Therapeutics Corp. engages in the development of gene therapy drugs. It uses CRISPR-GNDM, a gene modulation technology that assists patients fighting with genetic disorders. The company was founded by Haruhiko Morita and Osamu Nureki in January 2016 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4883 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company